Post-marketing surveillance study to evaluate the clinical utility of ACRODAT® in an international, multicentre, randomised, non-interventional study

Clinical Studies - Dec 1, 2021 - Dec 31, 2025

Aborted

Project leader: Bilz Stefan
Members: Räss Andrea, Grillmayr Victoria

Personal Health Coaching für Patient*innen mit Diabetes Typ 2

Clinical Studies - Apr 1, 2021 - Dec 31, 2030

Ongoing

Project leader: Bilz Stefan
Members: Räss Andrea, Grillmayr Victoria

Targeted correction of plasma sodium levels in hospitalized patients with hyponatremia: a randomized, controlled, parallel-group trial with blinded outcome assessment

Clinical Studies - Feb 1, 2021 - Dec 31, 2025

Ongoing

Project leader: Bilz Stefan
Members: Bontognali Martina, Räss Andrea, Rothlin Silvia, Grillmayr Victoria

A randomized, double-blind, placebo-controlled, multi-Center Phase 2 study to assess the efficacy and safety of oral BAY 2327949 in patients with clinical diagnosis of chronic kidney disease due to diabetes or hypertension and at least one cardiovasc...

Clinical Studies - Dec 1, 2020 - Dec 31, 2021

Aborted

Project leader: Bilz Stefan
Members: Räss Andrea, Grillmayr Victoria

Nicht-interventionelle, multizentrische, prospektive Studie zur Erfassung der glykämischen Variabilität in Diabetes mellitus Typ 1 Patienten nach Umstellung auf Insulin glargin 300 E/ml (Gla-300) (wegen unzureichender glykämischer Kontrolle) in Kom...

Clinical Studies - Dec 1, 2020 - Mar 1, 2022

Automatically Closed

Project leader: Bilz Stefan
Members: Räss Andrea, Grillmayr Victoria

An international, multicenter, prospective, non-interventional registry for patients with X-linked hypophosphatemia (XLH)

Clinical Studies - Dec 1, 2020 - Dec 31, 2030

Ongoing

Project leader: Bilz Stefan
Members: Räss Andrea, Grillmayr Victoria

The primary objective is to investigate the glycaemic control in adult patients with type 2 diabetes (T2D) who have not previously been treated with injectable glucose-lowering medication and who initiate treatment with oral semaglutide according to...

Clinical Studies - Sep 1, 2020 - Sep 1, 2022

Automatically Closed

Project leader: Bilz Stefan
Members: Drescher Tilman, Grillmayr Victoria, Räss Andrea

A randomised, Double-Blind, Placebo-Controlled, Dose-Finding Phase IIb Study to assess the efficacy and safety of orally administered Epeleuton in Patients with Hypertriglyceridemia and Typ 2 Diabetes. Short Title: TRIglyceride And Glucose contro...

Clinical Studies - Sep 1, 2020 - Aug 31, 2021

Automatically Closed

Project leader: Bilz Stefan
Members: Veraguth Katja, Quarella Marino, Räss Andrea, Grillmayr Victoria

To assess the characteristics and management of very high risk and high risk patients requiring lipid modifying therapies and the use of healthcare resources associated with current patient management strategies, particularly with respect to the prev...

Clinical Studies - Jul 1, 2020 - Jun 30, 2022

Automatically Closed

Project leader: Bilz Stefan
Members: Räss Andrea, Grillmayr Victoria

Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: evaluation of calciuria in spot urine and 24-hours urine sample

Clinical Studies - Jul 1, 2020 - Dec 31, 2024

Ongoing

Project leader: Bilz Stefan
Members: Siegenthaler Martin, Koster Markus, Räss Andrea, Grillmayr Victoria

Die Studie soll die Hypothese prüfen, dass auch nach längerer Behandlungsdauer mit Prednison®, Spiricort® oder einem verwandten Produkt auf ein langsames Ausschleichen der Dosis verzichtet werden darf, ohne dass dadurch ein schlechterer Verlauf resul...

Clinical Studies - Jul 1, 2017 - Dec 31, 2025

Ongoing

Project leader: Brändle Michael
Members: Drescher Tilman, Baerlocher Lorenz, Hörburger David, Räss Andrea, Grillmayr Victoria